Summary & Overview
HCPCS M1454: New Clinical Item or Device
HCPCS Level II code M1454 denotes a service described as “New cied,” indicating a newly introduced clinical item or device used in patient care. Nationally, clear coding for new devices and supplies matters for claims consistency, supply chain tracking, and payer coverage decisions. HCPCS codes for devices inform reimbursement pathways, provider billing practices, and payer policy design.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise reference to what the code represents, the likely clinical context and site of service, and the scope of available information. The publication outlines benchmark considerations, the clinical context for adoption of new items, and the typical documentation elements payers expect.
This summary is intended for national audiences including providers, billing professionals, and policy analysts seeking a rapid orientation to HCPCS Level II code M1454 and its role in billing for new clinical items or devices. Data not provided in the input—such as specific payer policies, modifiers, taxonomies, ICD-10 pairings, related codes, and service-line categorizations—are noted as unavailable and are not included.
Billing Code Overview
HCPCS Level II code M1454 is described as New cied. This code represents a service or supply characterized in the billing descriptor as "New cied." Based on the description, the service type is: Unspecified new clinical item or device. The typical site of service is: Outpatient clinic or ambulatory care setting, derived from the descriptor suggesting a new clinical device or item introduced in routine care.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult evaluated in an outpatient cardiology or electrophysiology clinic for initial implantation of a cardiac implantable electronic device (CIED). The patient has symptomatic bradycardia due to sick sinus syndrome or high-grade atrioventricular block, or requires a new implant for cardiac resynchronization therapy with or without defibrillation capability. The clinical workflow begins with pre-procedure evaluation including history, medication reconciliation (anticoagulation management), baseline ECG and echocardiogram, informed consent, and device and lead selection. On the day of service the patient undergoes venous access, device pocket creation, lead placement and testing, device programming, and hemostasis. Post-procedure care includes chest X-ray to confirm lead position, device interrogation, wound care instructions, and short-term follow-up for incision check and device interrogation programming adjustments. Typical sites of service include hospital inpatient, hospital outpatient (same-day surgery), or ambulatory surgery center depending on facility capability and patient comorbidity.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated Evaluation and Management (E/M) service by the same physician during a postoperative period | Use when a medically necessary E/M unrelated to the device implantation occurs during the global period |